Results 111 to 120 of about 75,548 (336)
Advanced Science, EarlyView.The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu +13 more
wiley +1 more source
Menopause Review, 2011 Endometrial carcinoma is one of the most common neoplasms in gynaecological oncology. The 5-year overallsurvival rate depends on the FIGO stage. For patients with stage I endometrial cancer it is estimated as 80%.Traditionally, the main treatment of ...
Paweł Pawłowicz +4 more
doaj
A Rare Case Report of Perivascular Epithelioid Cell Neoplasm (PEComa) In A 54-Year-Old Woman With Endometrial Polyp [PDF]
, 2023 Yi Lee, Yin-Shium Bai, Chang Yin
openalex +1 more source
Clinical and histopathological characteristics in patients with postmenopausal bleeding [PDF]
, 2013 Background: Incidence of endometrial carcinoma in Vojvodina is 15-20/100 000. In 75% cases, endometrial carcinoma is diagnosed in postmenopausal period. In 90 % of patients, the first clinical sign is postmenopausal bleeding.
Gutić Bojana +4 more
core +1 more source
Advanced Science, EarlyView.Ovarian cancer patients with high levels of mortalin protein in their tumors have worse survival. The investigational drug SHetA2 interferes with mortalin's support of mitochondria. The resulting mitochondrial damage causes a process called mitophagy that contributes to how SHetA2 kills cancer cells. Noncancerous cells repair their mitochondria through
Vishal Chandra +9 more
wiley +1 more source
Müllerian Adenosarcoma of the Urinary Bladder: Clinicopathologic and Immunohistochemical Features with Novel Genetic Aberrations [PDF]
, 2017 Müllerian adenosarcoma is a biphasic neoplasm most commonly of the uterus and less frequently of the ovary. It has been rarely described to occur in other sites such as peritoneum and liver.
Cheng, Liang +8 more
core +1 more source
Advanced Science, EarlyView.This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou +8 more
wiley +1 more source
ggalign: Bridging the Grammar of Graphics and Biological Multilayered Complexity
Advanced Science, EarlyView.The ggalign package provides a comprehensive framework for composable visualization built on top of ggplot2. Its primary purpose is to enable the construction of complex multi‐plot layouts with consistent observation alignment across plots, particularly for high‐dimensional data contexts such as genomics, transcriptomics, and microbiome studies ...
Yun Peng +9 more
wiley +1 more source
Benchmarking Ploidy Estimation Methods for Bulk and Single‐Cell Whole Genome Sequencing
Advanced Science, EarlyView.It comprehensively benchmarks computational tools for ploidy estimation from bulk and single‐cell whole‐genome sequencing data. The results highlight the strengths and limitations of each method under different conditions and identify PURPLE and SeCNV show top performance in bulk and single‐cell settings, respectively.
Yawei Song +8 more
wiley +1 more source
Prevalence of neoplasms in patients with acromegaly – the need for a national registry
Annals of Agricultural and Environmental Medicine, 2018 Introduction Acromegaly is an endocrine disorder caused predominantly by pituitary adenoma leading to autonomic oversecretion of growth hormone and secondary elevation of insulin-like growth factor 1 (IGF-1).
Beata Matyjaszek-Matuszek +4 more
doaj +1 more source